ArticleBMC cancer2025

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting.

Lu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.